Apollo System for ADHD

MB
Overseen ByMatthew B Pontifex, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Michigan State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests the Apollo System, a device designed to reduce ADHD (Attention Deficit Hyperactivity Disorder) symptoms. The study compares the effects of the real device with a placebo version that doesn't work, to determine the Apollo System's effectiveness. It suits kids and teens diagnosed with or suspected of having ADHD, especially if previous treatments were ineffective or current medications cause issues or don't fully manage symptoms. Participants must have normal or corrected vision and should not have certain other conditions or use specific drugs. As an unphased trial, this study provides a unique opportunity to explore new treatment options for ADHD.

Do I have to stop taking my current medications for the trial?

The trial does not specify if you need to stop taking your current medications. However, you cannot have started a new treatment within the last 30 days, and you cannot be on a beta blocker.

What prior data suggests that the Apollo System is safe for ADHD?

Research on the Apollo System for ADHD lacks extensive direct safety data. However, the "Not Applicable" phase label may indicate prior approval for other uses, suggesting some existing safety evidence. The Apollo System may have been used in other contexts and found to be generally safe.

Devices reaching this stage of testing have typically shown good tolerance in earlier research, reducing the likelihood of serious side effects. Nonetheless, participants should monitor their well-being during the trial and report any unusual symptoms to the study team.12345

Why are researchers excited about this trial?

Unlike traditional treatments for ADHD, which often rely on medications like stimulants and non-stimulants, the Apollo System offers a unique approach through wearable technology. This device uses gentle vibrations to potentially influence the autonomic nervous system, aiming for a calming effect without the side effects associated with medication. Researchers are excited about this treatment because it provides a non-invasive, drug-free alternative that could complement or replace current options, especially for those who may not respond well to medication. Additionally, the ability to use the Apollo System discreetly throughout the day offers flexibility and ease of use for individuals managing ADHD.

What evidence suggests that the Apollo System is effective for ADHD?

Research has shown that the Apollo System, which uses gentle vibrations, might help reduce ADHD symptoms in children. This trial will compare the effects of the Commercial Apollo System Device with a Sham Apollo System Device. Although detailed results from specific studies are not yet available, earlier research suggests that technology-based methods can lead to small but meaningful improvements in children with ADHD. These methods typically aim to improve focus and reduce impulsive actions. While this technology is new, it aligns with existing evidence that non-drug treatments can be beneficial for managing ADHD. The Apollo System's use of vibrations represents a promising new approach based on these early findings.12678

Who Is on the Research Team?

MB

Matthew B Pontifex, PhD.

Principal Investigator

Michigan State University

Are You a Good Fit for This Trial?

This trial is for children aged 8-18 with ADHD who have had minimal relief from current treatments, tried multiple treatments without meeting goals, still experience symptoms on medication, or suffer from medication side effects. It's open to all genders and ethnicities.

Inclusion Criteria

I am between 8 and 17 years old.
I've tried multiple treatments for over a year with little relief or have uncontrollable side effects.
Participants must have normal or corrected-to-normal vision in order to complete the cognitive task
See 3 more

Exclusion Criteria

Lack of consent
I have not started any new treatments in the last 30 days.
Participants cannot have previously used the Apollo System
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Apollo System or a sham device for 8 weeks

8 weeks
Pre and posttest assessments

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Apollo System

Trial Overview

The Apollo System is being tested over an 8-week period at home to see if it can reduce ADHD symptoms in children who meet the study criteria.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Commercial Apollo System DeviceExperimental Treatment1 Intervention
Group II: Sham Apollo System DevicePlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Michigan State University

Lead Sponsor

Trials
202
Recruited
687,000+

The Board of Medicine

Collaborator

Trials
3
Recruited
600+

The Board of Medicine

Collaborator

Trials
4
Recruited
800+

Citations

Efficacy of the Apollo System for Children With ADHD

The objective of this project is to understand the potential therapeutic benefits of the Apollo System for children with ADHD. Using vibrational therapy ...

Efficacy of the Apollo System for Children With ADHD

Description. The objective of this project is to understand the potential therapeutic benefits of the Apollo System for children with ADHD.

3.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/16961429/

Effectiveness outcomes in attention-deficit/hyperactivity ...

This article will discuss the methodology needed to demonstrate empirically the impact of treatment on actual burden of illness in practice.

Effectiveness of an Intervention Program Based on New ...

Results showed significant within-group improvements in both groups. The control group exhibited gains in sustained attention and inhibitory control (CARAS-R ...

Real-world effectiveness of a widely available digital health ...

We examined real-world evidence on whether Lumosity, a remote digital health technology designed to deliver cognitive training to healthy adults ...

Attention Deficit-Hyperactivity Disorder (ADHD)

A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD). Completed, NCT00152035 ...

7.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/19621975/

Efficacy and safety limitations of attention-deficit ...

This article focuses on the evaluation of the efficacy and safety profiles of medications used for the management of ADHD.

Attention Deficit Hyperactivity Disorder (ADHD) - Causes, ...

ADHD is characterized by a number of persistent difficulties, including difficulty in focusing, hyperactivity, and impulsive behavior.